This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Orencia
  • /
  • Inhibition of Co-Stimulation in Rheumatoid Arthrit...
Clinical trial

Inhibition of Co-Stimulation in Rheumatoid Arthritis (ICoSRA)

Read time: 1 mins
Last updated:1st Jan 2016

The purpose of this study is to use abatacept as a clinical molecular probe to evaluate the effects of inhibiting costimulation on immune responses in patients with rheumatoid arthritis (RA).


Study Type: Interventional
Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Inhibition of Co-Stimulation in Rheumatoid Arthritis
Estimated Enrollment: 25
Study Start Date: January 2016
Estimated Study Completion Date: January 2019
Estimated Primary Completion Date: January 2019 (Final data collection date for primary outcome measure)

Arms:
- Experimental:
Abatacept

Category Value
Study start date 2016-01-01

View full details